Literature DB >> 21791657

The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions.

Joshua T Schiffer1, Anna Wald, Stacy Selke, Lawrence Corey, Amalia Magaret.   

Abstract

BACKGROUND: Herpes simplex virus type 2 (HSV-2) reactivations in the genital tract are responsible for mucocutaneous lesions and transmission and manifest as discrete shedding episodes.
METHODS: We analyzed duration, peak copy number, and expansion and decay rates of 1020 shedding episodes in 531 immunocompetent HSV-2-seropositive persons from whom daily swabs of genital secretions were collected.
RESULTS: Viral quantity varied by as much as a multiple of 10 million in a single person over time. Peak episode copy number was distributed approximately evenly from 10(3) through 10(8) HSV DNA copies/mL. Median rate of increase was 10(7.6) HSV DNA copies/day during the first 12 hours of an episode and 10(5) copies/d from episode initiation to peak. These values depended only moderately on episode duration. Median decay rate was -10(6.2) HSV DNA copies/d during the final 12 hours of an episode and -10(3.6) copies/d from peak to termination. Episodes lasted a median of 3 days (interquartile range, 1-8 days). Prolonged (>5 days) episodes were associated with nonmonotonic decay.
CONCLUSIONS: HSV-2 shedding episodes are notable for rapid expansion and decay and extreme heterogeneity of duration and viral production. The net effect of these dynamic episodes is frequent shedding at high copy numbers.

Entities:  

Mesh:

Year:  2011        PMID: 21791657      PMCID: PMC3144170          DOI: 10.1093/infdis/jir314

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model.

Authors:  P M Odell; K M Anderson; R B D'Agostino
Journal:  Biometrics       Date:  1992-09       Impact factor: 2.571

2.  Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts.

Authors:  G J Mertz; O Schmidt; J L Jourden; M E Guinan; M L Remington; A Fahnlander; C Winter; K K Holmes; L Corey
Journal:  Sex Transm Dis       Date:  1985 Jan-Mar       Impact factor: 2.830

3.  Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling.

Authors:  Catherine M Crespi; William G Cumberland; Anna Wald; Lawrence Corey; Sally Blower
Journal:  Sex Transm Infect       Date:  2007-05-02       Impact factor: 3.519

4.  Virologic characteristics of subclinical and symptomatic genital herpes infections.

Authors:  A Wald; J Zeh; S Selke; R L Ashley; L Corey
Journal:  N Engl J Med       Date:  1995-09-21       Impact factor: 91.245

5.  Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.

Authors:  Karen E Mark; Anna Wald; Amalia S Magaret; Stacy Selke; Laura Olin; Meei-Li Huang; Lawrence Corey
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

6.  Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Authors:  A Wald; J Zeh; G Barnum; L G Davis; L Corey
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

7.  Risk factors for the sexual transmission of genital herpes.

Authors:  G J Mertz; J Benedetti; R Ashley; S A Selke; L Corey
Journal:  Ann Intern Med       Date:  1992-02-01       Impact factor: 25.391

8.  Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

Authors:  J B Dinoso; S Y Kim; A M Wiegand; S E Palmer; S J Gange; L Cranmer; A O'Shea; M Callender; A Spivak; T Brennan; M F Kearney; M A Proschan; J M Mican; C A Rehm; J M Coffin; J W Mellors; R F Siliciano; F Maldarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

9.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

10.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

View more
  35 in total

1.  Viral kinetics of genital herpes: a molecular probe into host-viral interactions.

Authors:  Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

Review 2.  Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.

Authors:  Joshua T Schiffer; Sami L Gottlieb
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

3.  An effector phenotype of CD8+ T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection.

Authors:  Tao Peng; Jia Zhu; Khamsone Phasouk; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

4.  Rapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.

Authors:  Joshua T Schiffer; David A Swan; Lawrence Corey; Anna Wald
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

5.  Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.

Authors:  Joshua T Schiffer; Amalia Magaret; Stacy Selke; Lawrence Corey; Anna Wald
Journal:  J Antimicrob Chemother       Date:  2011-08-24       Impact factor: 5.790

6.  Increased Frequency of Virus Shedding by Herpes Simplex Virus 2-Infected Guinea Pigs in the Absence of CD4+ T Lymphocytes.

Authors:  Nigel Bourne; Clarice L Perry; Brianne N Banasik; Aaron L Miller; Mellodee White; Richard B Pyles; Hubert Schäfer; Gregg N Milligan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

7.  Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Authors:  Christine Johnston; Jia Zhu; Lichen Jing; Kerry J Laing; Christopher M McClurkan; Alexis Klock; Kurt Diem; Lei Jin; Jeffrey Stanaway; Elizabeth Tronstein; William W Kwok; Meei-Li Huang; Stacy Selke; Youyi Fong; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons.

Authors:  Emily S Ford; Amalia S Magaret; Cedric W Spak; Stacy Selke; Steve Kuntz; Lawrence Corey; Anna Wald
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

Review 9.  Viral kinetic modeling: state of the art.

Authors:  Laetitia Canini; Alan S Perelson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-06-25       Impact factor: 2.745

10.  Dynamics of Persistent Oral Cytomegalovirus Shedding During Primary Infection in Ugandan Infants.

Authors:  Bryan T Mayer; Laura Matrajt; Corey Casper; Elizabeth M Krantz; Lawrence Corey; Anna Wald; Soren Gantt; Joshua T Schiffer
Journal:  J Infect Dis       Date:  2016-09-20       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.